A new breast cancer vaccine shows such promising signs that researchers are anxious to begin testing it on human patients, reports CNN
Scientists at Ohio's Cleveland Clinic say that a single vaccination not only prevented breast cancer tumors from growing in mice, but it also stalled the growth of already existing tumors.
Dr Vincent Tuohy, lead investigator of the research, explains that the vaccine uses a protein that is found in most breast cancers. The vaccine works with the immune system to focus on the protein and leave healthy breast tissue alone, reports the news provider.
"We can protect women from breast cancer, but if it destroyed their normal breast, it's an unacceptable side effect, so we had to avoid that," Dr Tuohy told the news source.
The next step for researchers is working with the United States Food and Drug Administration (FDA). The FDA will help them by outlining what studies they want to see conducted before human trials can commence. Researchers are also waiting for funding to begin human trials.
According to the Center for Disease Control and Prevention (CDC), one in eight women will be diagnosed with breast cancer at some point during their lifetime.